Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: perspectives from Taiwan

7 月 31, 2020 轉譯文章

本文描述台灣細胞病理學實驗室的感染控制與預防。

(財團法人國家衛生研究院 莊淑鈞博士摘要整理)

Author：Chien-Chin Chen, Chia-Yu Chi

原文連結：https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncy.22280

Related Post

輝瑞/BNT和默德納mRNA疫苗可有效預防COVID-19及減輕疾病：真實世界的保護力數據 (Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines)

7 月 26, 2021

劃錯重點—初級保健如何克服Covid-19疫苗的“猶豫” (Missing the Point — How Primary Care Can Overcome Covid-19 Vaccine Hesitancy)

7 月 21, 2021

新冠病毒Delta變異株對中和抗體的感受性降低 (Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization)

7 月 19, 2021